SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063353
Filing Date
2023-11-14
Accepted
2023-11-14 07:30:33
Documents
90
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q itrm-20230930.htm   iXBRL 10-Q 3538860
2 EX-31.1 itrm-ex31_1.htm EX-31.1 18966
3 EX-31.2 itrm-ex31_2.htm EX-31.2 19263
4 EX-32.1 itrm-ex32_1.htm EX-32.1 11357
5 EX-32.2 itrm-ex32_2.htm EX-32.2 11349
  Complete submission text file 0000950170-23-063353.txt   13322585

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itrm-20230930_def.xml EX-101.DEF 368967
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itrm-20230930.xsd EX-101.SCH 92816
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itrm-20230930_lab.xml EX-101.LAB 658006
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itrm-20230930_cal.xml EX-101.CAL 59473
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itrm-20230930_pre.xml EX-101.PRE 524800
84 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20230930_htm.xml XML 2573527
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38503 | Film No.: 231401590
SIC: 2834 Pharmaceutical Preparations